These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 23278525)
1. Assessment of protein expression and gene status of human epidermal growth factor receptor (HER) family molecules in ameloblastomas. Oikawa M; Miki Y; Shimizu Y; Kumamoto H J Oral Pathol Med; 2013 May; 42(5):424-34. PubMed ID: 23278525 [TBL] [Abstract][Full Text] [Related]
2. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas. Kumamoto H; Takahashi N; Ooya K J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485 [TBL] [Abstract][Full Text] [Related]
3. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas. Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490 [TBL] [Abstract][Full Text] [Related]
4. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Cho EY; Choi YL; Han JJ; Kim KM; Oh YL Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study. Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G J Transl Med; 2015 May; 13():171. PubMed ID: 26021752 [TBL] [Abstract][Full Text] [Related]
6. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors. Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766 [TBL] [Abstract][Full Text] [Related]
7. Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. Sassen A; Rochon J; Wild P; Hartmann A; Hofstaedter F; Schwarz S; Brockhoff G Breast Cancer Res; 2008; 10(1):R2. PubMed ID: 18182100 [TBL] [Abstract][Full Text] [Related]
8. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression. Willmore-Payne C; Holden JA; Layfield LJ Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological evaluation of 164 dental follicles and dentigerous cysts with emphasis on the presence of odontogenic epithelium in the connective tissue. The hypothesis of "focal ameloblastoma". Meleti M; van der Waal I Med Oral Patol Oral Cir Bucal; 2013 Jan; 18(1):e60-4. PubMed ID: 23085710 [TBL] [Abstract][Full Text] [Related]
10. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion. Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194 [TBL] [Abstract][Full Text] [Related]
11. Low expression of HER2 protein in breast cancer is biologically significant. Tovey SM; Reeves JR; Stanton P; Ozanne BW; Bartlett JM; Cooke TG J Pathol; 2006 Nov; 210(3):358-62. PubMed ID: 16981252 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical assessment of ATG7, LC3, and p62 in ameloblastomas. Okada M; Oikawa M; Miki Y; Shimizu Y; Echigo S; Takahashi T; Kumamoto H J Oral Pathol Med; 2014 Sep; 43(8):606-12. PubMed ID: 24762217 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression. Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712 [TBL] [Abstract][Full Text] [Related]
14. Dual gain of HER2 and EGFR gene copy numbers impacts the prognosis of carcinoma ex pleomorphic adenoma. Nishijima T; Yamamoto H; Nakano T; Nakashima T; Taguchi K; Masuda M; Motoshita J; Komune S; Oda Y Hum Pathol; 2015 Nov; 46(11):1730-43. PubMed ID: 26345124 [TBL] [Abstract][Full Text] [Related]
15. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. da Silva TA; Batista AC; Mendonça EF; Leles CR; Fukada S; Cunha FQ Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):333-41. PubMed ID: 18061491 [TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195 [TBL] [Abstract][Full Text] [Related]
17. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas. Kumamoto H; Ooya K J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896 [TBL] [Abstract][Full Text] [Related]
18. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. Witton CJ; Reeves JR; Going JJ; Cooke TG; Bartlett JM J Pathol; 2003 Jul; 200(3):290-7. PubMed ID: 12845624 [TBL] [Abstract][Full Text] [Related]